Skip to main content

and
  1. No Access

    Article

    Efficacy and Safety of Fentanyl Citrate Patch, Including a Low-Dose 0.5 mg Formulation, in Opioid-Naïve Patients with Cancer Pain

    The use of transdermal fentanyl for opioid-naïve patients is restricted, however, transdermal fentanyl is a useful opioid analgesic for patients in whom oral administration is difficult or for those with renal...

    Shigeki Yamaguchi, Eiji Uchida, Takaaki Terahara, Koji Okawa in Clinical Drug Investigation (2020)

  2. No Access

    Article

    An Open-Label Study of the Pharmacokinetics and Tolerability of Once-a-Day Fentanyl Citrate Patch in Japanese Pediatric and Adolescent Patients with Cancer Pain

    Transdermal fentanyl is not yet approved for pediatric and adolescent use in Japan.

    Eiso Hiyama, Shigeki Yamaguchi, Koji Okawa in Clinical Drug Investigation (2021)

  3. Article

    Open Access

    Remimazolam Compared to Propofol for Total Intravenous Anesthesia with Remifentanil on the Recovery of Psychomotor Function: A Randomized Controlled Trial

    This study aimed to compare remimazolam to propofol in psychomotor recovery after total intravenous anesthesia (TIVA) using the Trieger dot test.

    Takahito Shimizu, Toshifumi Takasusuki, Shigeki Yamaguchi in Advances in Therapy (2023)

  4. Article

    Open Access

    Effect of Remifentanil on the Tpeak-Tend Interval During Electroconvulsive Therapy

    QT interval dispersion, which reflects the regional heterogeneity of ventricular repolarization, increases during electroconvulsive therapy (ECT). Tpeak-Tend (TpTe) is considered a new marker of the transmural...

    Kozue Eda, Kazuya Akutsu, Toshifumi Takasusuki, Shigeki Yamaguchi in Advances in Therapy (2024)